Lipocine Signs License Deal with SPC Korea to Commercialize TLANDO in South Korea
Under the terms of the distribution and license agreement, Lipocine will receive an upfront payment and is also eligible to receive certain regulatory and sales milestone payments, including payment upon regulatory approval of TLANDO in South Korea.
Testosterone Replacement Therapy | 04/11/2024 | By Aishwarya | 363
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy